TrialBritish journal of cancer2019

Patterns of response with talimogene laherparepvec in combination with ipilimumab or ipilimumab alone in metastatic unresectable melanoma.

Jason Chesney et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.